Overview

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

Status:
Completed

Trial end date:
2013-02-01

Target enrollment:

Participant gender:

Summary

This is an intra-individual titration study of KRN1493 to evaluate the safety and efficacy of KRN1493 for the treatment of hypercalcemia in patients with parathyroid carcinoma or intractable primary hyperparathyroidism (PHPT).

Phase:

Phase 3

Details

Lead Sponsor:

Kyowa Hakko Kirin Company, Limited
Kyowa Kirin Co., Ltd.

Treatments:

Cinacalcet
Cinacalcet Hydrochloride